Novartis Drug Cuts Heart Inflammation in New Study

A newly tested Novartis drug successfully reduced inflammation markers that contribute to heart disease, bringing hope for better cardiovascular treatments.

Higher doses showed even stronger results, proving the medicine works as designed.